Anti-Apha 1 Acid Glycoprotein Antibody

Raised in goat and supplied as an IgG fraction, this polyclonal antibody targets Alpha-1 acid glycoprotein (AGP), a heavily glycosylated acute-phase serum protein produced in the liver. Unconjugated and formulated as a liquid IgG fraction, it ships ready to use at 10 mL per vial for bench workflows that demand a generous working volume. Researchers apply it to ELISA plates and immunoelectrophoresis (IEP) gels where it functions as a detection or capture reagent, taking advantage of its polyclonal character to recognize multiple epitopes on the AGP molecule, which improves tolerance for the protein's naturally occurring glycoform and sequence heterogeneity.

Alpha-1 acid glycoprotein rises sharply in response to inflammation, tissue injury, infection, malignancy, and pregnancy, and investigators track the protein to monitor acute-phase status in preclinical and clinical studies. The antibody is also a useful reagent in pharmacokinetic research, because AGP binds a broad spectrum of basic and neutral drugs and influences their free fraction in circulation. Within Antibodies.com's catalogue of Primary Antibodies, the reagent supports routine immunoassay development and classical protein characterization using immunoelectrophoresis, making it a versatile addition to labs studying acute-phase biology, drug-protein binding, or biomarker discovery.